GSN and Sepsis: Importantly, it was noted that subcutaneous or intravenous injection of exogenous pGSN after LPS challenge or CLP in a dose ~20 times higher than total gelsolin concentration in blood (calculated based on the weight of the animal and volume of blood), significantly improved illness outcome via solubilization of circulating actin aggregates in both mice and rat model of sepsis [85,86].